CASI Pharmaceuticals
CASI
#10175
Rank
NZ$33.02 M
Marketcap
NZ$1.61
Share price
10.85%
Change (1 day)
-72.81%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.35

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.50. In 2024 the company made an earnings per share (EPS) of NZ-$4.40 a decrease over its 2023 EPS that were of NZ-$3.47.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.35-1.21%
2024NZ-$4.4026.73%
2023NZ-$3.47-32.89%
2022NZ-$5.1711.9%
2021NZ-$4.62-38.44%
2020NZ-$7.51-8.96%
2019NZ-$8.2550%
2018NZ-$5.5077.78%
2017NZ-$3.095.88%
2016NZ-$2.92-22.73%
2015NZ-$3.78-76.09%
2014NZ-$15.82318.18%
2013NZ-$3.78-71.79%
2012NZ-$13.4165.96%
2011NZ-$8.08-50%
2010NZ-$16.16-18.97%
2009NZ-$19.94-63.64%
2008NZ-$54.843.57%
2007NZ-$52.95-60.56%
2006NZ-$134.2697.22%
2005NZ-$68.08-2.7%
2004NZ-$69.97-45.59%
2003NZ-$128.59-61.8%
2002NZ-$336.60-25.52%
2001NZ-$451.95-21.38%
2000NZ-$574.8713.86%
1999NZ-$504.90149.53%
1998NZ-$202.3498.15%
1997NZ-$102.1110.2%
1996NZ-$92.66